Liquidia Technologies Inc (LQDA)

Currency in USD
35.240
-0.540(-1.51%)
Closed·
36.090+0.850(+2.41%)
·
LQDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.06036.090
52 wk Range
11.26036.110
Key Statistics
Prev. Close
35.78
Open
35.6
Day's Range
35.06-36.09
52 wk Range
11.26-36.11
Volume
627.45K
Average Volume (3m)
2.18M
1-Year Change
208.04%
Book Value / Share
0.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LQDA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44.000
Upside
+24.86%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Liquidia Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Employees
170

Liquidia Technologies Inc Earnings Call Summary for Q3/2025

  • Liquidia Technologies (LQDA) reported Q3 2025 EPS of -$0.04 vs -$0.41 forecast, with revenue of $54.34M exceeding expectations by 196.45%, driving stock up 11.49% pre-market.
  • The company achieved positive adjusted EBITDA of $10.1M and its first month of positive net cash flow in September, with $157.5M cash on hand.
  • Utrepia's launch has significantly penetrated the inhaled prostacyclin therapy market, with CEO Roger Jeffs stating it's 'redefining expectations for inhaled delivery of treprostinil.'
  • Future plans include clinical studies for transitioning PAH patients, potential studies in IPF/PPF, development of sustained-release formulation L606, and preparation for the global RESPIRE study.
  • Ongoing litigation with United Therapeutics remains a key risk, with judicial decisions expected between now and Q1 2026 potentially impacting market position.
Last Updated: 03/11/2025, 14:42
Read Full Transcript

Compare LQDA to Peers and Sector

Metrics to compare
LQDA
Peers
Sector
Relationship
P/E Ratio
−24.7x−7.4x−0.6x
PEG Ratio
−2.950.160.00
Price/Book
139.0x1.8x2.6x
Price / LTM Sales
44.3x6.8x3.2x
Upside (Analyst Target)
33.4%81.3%41.8%
Fair Value Upside
Unlock5.8%5.1%Unlock

Analyst Ratings

8 Buy
0 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 44.000
(+24.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Sell16.00-54.60%6.00Maintain05/11/2025
H.C. Wainwright
Buy50.00+41.88%35.00Maintain05/11/2025
Raymond James
Buy47.00+33.37%41.00Maintain04/11/2025
Jefferies
Buy45.00+27.70%43.00Maintain03/11/2025
BofA Securities
Buy39.00+10.67%37.00Maintain03/11/2025

Earnings

Latest Release
Nov 03, 2025
EPS / Forecast
-0.04 / -0.41
Revenue / Forecast
54.34M / 18.33M
EPS Revisions
Last 90 days

People Also Watch

27.67
OLMA
-1.81%
27.450
KOD
-4.05%
18.920
DBVT
-6.66%
20.41
DYN
-1.78%
33.230
SYRE
-2.84%

FAQ

What Is the Liquidia Technologies (LQDA) Share Price Today?

The live Liquidia Technologies share price today is 35.240

What Stock Exchange Does Liquidia Technologies (LQDA) Trade On?

Liquidia Technologies is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Liquidia Technologies?

The stock symbol (also called a 'ticker') for Liquidia Technologies is "LQDA."

What Is the Current Liquidia Technologies Market Cap?

As of today, Liquidia Technologies market capitalisation is 3.07B.

What Is Liquidia Technologies's (LQDA) Earnings Per Share (TTM)?

The Liquidia Technologies EPS is currently -1.45 (Trailing Twelve Months).

When Is the Next Liquidia Technologies Earnings Date?

Liquidia Technologies's next earnings report will be released on 12 Mar 2026.

Is LQDA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Liquidia Technologies moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Liquidia Technologies Stock Split?

Liquidia Technologies has split 0 times. (See the LQDA stock split history page for full effective split date and price information.)

How Many Employees Does Liquidia Technologies Have?

Liquidia Technologies has 170 employees.

What is the current trading status of Liquidia Technologies (LQDA)?

As of 24 Dec 2025, Liquidia Technologies (LQDA) is trading at a price of 35.240, with a previous close of 35.780. The stock has fluctuated within a day range of 35.060 to 36.090, while its 52-week range spans from 11.260 to 36.110.

What Is Liquidia Technologies (LQDA) Price Target According to Analysts?

The average 12-month price target for Liquidia Technologies is USD44, with a high estimate of USD67 and a low estimate of USD16. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +24.86% Upside potential.

What Is the LQDA Premarket Price?

LQDA's last pre-market stock price is 36.129. The pre-market share volume is 790.000, and the stock has decreased by 0.349, or 0.980%.

What Is the LQDA After Hours Price?

LQDA's last after hours stock price is 36.090, the stock has decreased by 0.850, or 2.410%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.